Table I Index
Table of Contents
|
Table I - 53 Monroe Incidence Rate1 by Primary Site and Sex: Cases Diagnosed in 1996, Indiana |
||||||
Primary Site |
Total |
Males | Females | |||
| Number | Rate | Number | Rate | Number | Rate | |
| All sites | 398 | 399.7 | 184 | 428.9 | 214 | 382.7 |
| Oral cavity and pharynx | 6 | 5.5** | * | # | * | # |
| Lip | * | # | * | # | * | # |
| Tongue | * | # | * | # | * | # |
| Major salivary glands | * | # | * | # | * | # |
| Floor of mouth | * | # | * | # | * | # |
| Gum and other mouth | * | # | * | # | * | # |
| Nasopharynx | * | # | * | # | * | # |
| Tonsil | * | # | * | # | * | # |
| Oropharynx | * | # | * | # | * | # |
| Hypopharynx | * | # | * | # | * | # |
| Pharynx and other oral cavity | * | # | * | # | * | # |
| Digestive system | 76 | 75.0 | 43 | 101.4 | 33 | 53.9 |
| Esophagus | * | # | * | # | * | # |
| Stomach | * | # | * | # | * | # |
| Small intestine | * | # | * | # | * | # |
| Colon excluding rectum | 40 | 39.9 | 22 | 53.1 | 18 | 29.0** |
| Rectum and rectosigmoid | 13 | 13.2** | 7 | 17.5** | 6 | 10.2** |
| Anus, anal canal, and anorectum | * | # | * | # | * | # |
| Liver and intrahepatic bile duct | * | # | * | # | * | # |
| Gallbladder | * | # | * | # | * | # |
| Other biliary | * | # | * | # | * | # |
| Pancreas | 9 | 8.6** | * | # | 6 | 10.3** |
| Retroperitoneum | * | # | * | # | * | # |
| Peritoneum | * | # | * | # | * | # |
| Other digestive organs | * | # | * | # | * | # |
| Respiratory system | 62 | 64.5 | 37 | 88.5 | 25 | 47.7 |
| Nasal cavity, ear, and sinuses | * | # | * | # | * | # |
| Larynx | 5 | 5.6** | 5 | 12.7** | * | # |
| Lung and bronchus | 56 | 58.2 | 31 | 73.7 | 25 | 47.7 |
| Trachea, pleura, and other respiratory organs | * | # | * | # | * | # |
| Bones and joints | * | # | * | # | * | # |
| Soft tissue (including heart) | * | # | * | # | * | # |
| Skin (excluding basal and squamous) | 13 | 11.8** | 9 | 18.6** | * | # |
| Melanoma of the skin | 13 | 11.8** | 9 | 18.6** | * | # |
| Other non-epithelial skin cancers | * | # | * | # | * | # |
| Breast | 65 | 64.4 | * | # | 65 | 118.4 |
| Female genital system | 34 | 34.9 | -- | -- | 34 | 64.3 |
| Cervix uteri | * | # | -- | -- | * | # |
| Corpus uteri | 22 | 24.1 | -- | -- | 22 | 44.0 |
| Uterus, NOS | * | # | -- | -- | * | # |
| Ovary | 8 | 7.3** | -- | -- | 8 | 13.5** |
| Vagina | * | # | -- | -- | * | # |
| Vulva | * | # | -- | -- | * | # |
| Other female genital organs | * | # | -- | -- | * | # |
| Male genital system | 36 | 39.3 | 36 | 88.4 | -- | -- |
| Prostate gland | 35 | 38.4 | 35 | 86.6 | -- | -- |
| Testis | * | # | * | # | -- | -- |
| Penis | * | # | * | # | -- | -- |
| Other male genital organs | * | # | * | # | -- | -- |
| Urinary system | 45 | 44.1 | 27 | 63.4 | 18 | 29.0** |
| Urinary bladder | 22 | 20.1 | 12 | 26.6** | 10 | 15.9** |
| Kidney and renal pelvis | 23 | 24.0 | 15 | 36.9** | 8 | 13.2** |
| Ureter | * | # | * | # | * | # |
| Other urinary organs | * | # | * | # | * | # |
| Eye and orbit | * | # | * | # | * | # |
| Brain and other nervous system | 7 | 7.2** | * | # | * | # |
| Brain | 7 | 7.2** | * | # | * | # |
| Other nervous system | * | # | * | # | * | # |
| Endocrine system | 9 | 9.0** | * | # | 8 | 16.2** |
| Thyroid gland | 9 | 9.0** | * | # | 8 | 16.2** |
| Other endocrine (including thymus) | * | # | * | # | * | # |
| Lymphoma | 18 | 17.4** | 10 | 21.2** | 8 | 12.9** |
| Hodgkin’s disease | * | # | * | # | * | # |
| Non-Hodgkin’s lymphoma | 16 | 16.0** | 8 | 18.5** | 8 | 12.9** |
| Multiple myeloma | * | # | * | # | * | # |
| Leukemia | 14 | 13.9** | 8 | 17.6** | 6 | 10.5** |
| Acute lymphocytic | * | # | * | # | * | # |
| Chronic lymphocytic | 5 | 5.4** | * | # | * | # |
| Acute myeloid | 6 | 6.0** | * | # | * | # |
| Chronic myeloid | * | # | * | # | * | # |
| Other leukemias | * | # | * | # | * | # |
| Other, ill-defined and unknown sites | 8 | 7.7** | * | # | * | # |
1 Per 100,000; Age-adjusted, 1970 U.S. Standard Million. Excludes in situ cancers except bladder, and also excludes basal and squamous cell carcinomas of the skin. * Fewer than 5 cases, number suppressed to protect confidentiality. ** Rates based on fewer than twenty cases are unstable. # Rate cannot be calculated. _______________________________________________________________ Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, January 2001 |
||||||